[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3884 Engrossed in House (EH)]

<DOC>
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
118th CONGRESS
  2d Session
                                H. R. 3884

_______________________________________________________________________

                                 AN ACT


 
 To amend title XI of the Public Health Service Act to reauthorize the 
  program providing for sickle cell disease and other heritable blood 
      disorders research, surveillance, prevention, and treatment.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Sickle Cell Disease and Other 
Heritable Blood Disorders Research, Surveillance, Prevention, and 
Treatment Act of 2023''.

SEC. 2. REAUTHORIZATION OF SICKLE CELL DISEASE AND OTHER HERITABLE 
              BLOOD DISORDERS RESEARCH, SURVEILLANCE, PREVENTION, AND 
              TREATMENT.

    Section 1106(b) of the Public Health Service Act (42 U.S.C. 300b-
5(b)) is amended--
            (1) in paragraph (3)(A), by inserting ``, grant, or 
        cooperative agreement'' after ``contract''; and
            (2) in paragraph (6), by striking ``$4,455,000 for each of 
        fiscal years 2019 through 2023'' and inserting ``$8,205,000 for 
        each of fiscal years 2024 through 2028''.

            Passed the House of Representatives September 23, 2024.

            Attest:

                                                                 Clerk.
118th CONGRESS

  2d Session

                               H. R. 3884

_______________________________________________________________________

                                 AN ACT

 To amend title XI of the Public Health Service Act to reauthorize the 
  program providing for sickle cell disease and other heritable blood 
      disorders research, surveillance, prevention, and treatment.